Cargando…

Author Correction: TRAF3 regulates the oncogenic proteins Pim2 and c-Myc to restrain survival in normal and malignant B cells

Detalles Bibliográficos
Autores principales:	Whillock, Amy L., Mambetsariev, Nurbek, Lin, Wai W., Stunz, Laura L., Bishop, Gail A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Author Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6864106/ https://www.ncbi.nlm.nih.gov/pubmed/31745166 http://dx.doi.org/10.1038/s41598-019-53669-2

Ejemplares similares

TRAF3 regulates the oncogenic proteins Pim2 and c-Myc to restrain survival in normal and malignant B cells
por: Whillock, Amy L., et al.
Publicado: (2019)

TRAF3 deficiency promotes metabolic reprogramming in B cells
por: Mambetsariev, Nurbek, et al.
Publicado: (2016)

The adaptor molecule TRAF3 restrains the lineage determination of thymic regulatory T cells by modulating interleukin-2 receptor signaling
por: Yi, Zuoan, et al.
Publicado: (2014)

TNF receptor-associated factor 3 restrains B-cell receptor signaling in normal and malignant B cells
por: Whillock, Amy L., et al.
Publicado: (2021)

TRAF3 Regulates Homeostasis of CD8(+) Central Memory T Cells
por: Yi, Zuoan, et al.
Publicado: (2014)

TRAF3 as a Multifaceted Regulator of B Lymphocyte Survival and Activation
por: Bishop, Gail A., et al.
Publicado: (2018)

The Tumor Suppressor Protein TRAF3 Modulates GSK3 Activity and Susceptibility of B Lymphoma Cells to GSK3 Inhibition
por: Hornick, Emma L., et al.
Publicado: (2022)

Author Correction: Human in vitro-induced regulatory T cells display Dlgh1 dependent and PKC-θ restrained suppressive activity
por: Zanin-Zhorov, Alexandra, et al.
Publicado: (2020)

The direct Myc target Pim3 cooperates with other Pim kinases in supporting viability of Myc-induced B-cell lymphomas
por: Forshell, Linus Plym, et al.
Publicado: (2011)

TRAF3: Guardian of T lymphocyte functions
por: Hornick, Emma L., et al.
Publicado: (2023)

Roles of the Kinase TAK1 in TRAF6-Dependent Signaling by CD40 and Its Oncogenic Viral Mimic, LMP1
por: Arcipowski, Kelly M., et al.
Publicado: (2012)

Author Correction: Eya3 partners with PP2A to induce c-Myc stabilization and tumor progression
por: Zhang, Lingdi, et al.
Publicado: (2018)

Author Correction: ELL targets c-Myc for proteasomal degradation and suppresses tumour growth
por: Chen, Yu, et al.
Publicado: (2023)

ADHFE1 is a MYC-linked oncogene that induces metabolic reprogramming and cellular de-differentiation in breast cancer
por: Mishra, Prachi, et al.
Publicado: (2018)

The distribution of the c-myc oncogene product in malignant lymphomas and various normal tissues as demonstrated by immunocytochemistry.
por: Jack, A. S., et al.
Publicado: (1986)

Author Correction: SmMYC2a and SmMYC2b played similar but irreplaceable roles in regulating the biosynthesis of tanshinones and phenolic acids in Salvia miltiorrhiza
por: Zhou, Yangyun, et al.
Publicado: (2020)

Author Correction: Combinatorial immunotherapies overcome MYC-driven immune evasion in triple negative breast cancer
por: Lee, Joyce V., et al.
Publicado: (2022)

Author Correction: Fundamental immune–oncogenicity trade-offs define driver mutation fitness
por: Hoyos, David, et al.
Publicado: (2022)

WNT-mediated gene gating: a novel principle connecting oncogenic super-enhancers with the nuclear pore to drive pathological expression of MYC
por: Göndör, Anita
Publicado: (2020)

Author Correction: Division of labour between Myc and G1 cyclins in cell cycle commitment and pace control
por: Dong, Peng, et al.
Publicado: (2018)

Author Correction: Co-targeting PIM and PI3K/mTOR using multikinase inhibitor AUM302 and a combination of AZD-1208 and BEZ235 in prostate cancer
por: Luszczak, Sabina, et al.
Publicado: (2020)

Epstein-Barr Functional Mimicry: Pathogenicity of Oncogenic Latent Membrane Protein-1 in Systemic Lupus Erythematosus and Autoimmunity
por: Munroe, Melissa E., et al.
Publicado: (2021)

Author Correction: Definition of Fiducial Points in the Normal Seismocardiogram
por: Sørensen, Kasper, et al.
Publicado: (2020)

Ewing sarcoma fusion oncogene: At the crossroads of transcription and DNA damage response
por: Gorthi, Aparna, et al.
Publicado: (2018)

A20 Enhances the Expression of the Proto-Oncogene C-Myc by Downregulating TRAF6 Ubiquitination after ALV-A Infection
por: Chen, Xueyang, et al.
Publicado: (2022)

Author Correction: Pharmacological inhibition of mTOR attenuates replicative cell senescence and improves cellular function via regulating the STAT3-PIM1 axis in human cardiac progenitor cells
por: Park, Ji Hye, et al.
Publicado: (2023)

Author Correction: MYC-driven epigenetic reprogramming favors the onset of tumorigenesis by inducing a stem cell-like state
por: Poli, Vittoria, et al.
Publicado: (2018)

Author Correction: A local tumor microenvironment acquired super-enhancer induces an oncogenic driver in colorectal carcinoma
por: Zhou, Royce W., et al.
Publicado: (2023)

Pim1 kinase synergizes with c-MYC to induce advanced prostate carcinoma
por: Wang, Jie, et al.
Publicado: (2010)

Author Correction: Immune cell composition in normal human kidneys
por: Park, Jun-Gyu, et al.
Publicado: (2021)

Author Correction: The Oncogenic Role of COL23A1 in Clear Cell Renal Cell Carcinoma
por: Xu, Fujiang, et al.
Publicado: (2018)

Editorial: TRAF Proteins in Health and Disease
por: Bishop, Gail A., et al.
Publicado: (2019)

Author Correction: USP4 positively regulates RLR-induced NF-κB activation by targeting TRAF6 for K48-linked deubiquitination and inhibits enterovirus 71 replication
por: Xu, Chao, et al.
Publicado: (2023)

Author Correction: Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England
por: Amirthalingam, Gayatri, et al.
Publicado: (2022)

Author Correction: Activation of liver stromal cells is associated with male-biased liver tumor initiation in xmrk and Myc transgenic zebrafish
por: Yang, Qiqi, et al.
Publicado: (2023)

Author Correction: PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma
por: Ribas, Antoni, et al.
Publicado: (2021)

Author Correction: Lineage-specific RUNX2 super-enhancer activates MYC and promotes the development of blastic plasmacytoid dendritic cell neoplasm
por: Kubota, Sho, et al.
Publicado: (2019)

Author Correction: Characterization of an RNA binding protein interactome reveals a context-specific post-transcriptional landscape of MYC-amplified medulloblastoma
por: Kameda-Smith, Michelle M., et al.
Publicado: (2023)

Inhibition of the Pim1 Oncogene Results in Diminished Visual Function
por: Yin, Jun, et al.
Publicado: (2012)

Author Correction: Myeloid lineage enhancers drive oncogene synergy in CEBPA/CSF3R mutant acute myeloid leukemia
por: Braun, Theodore P., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bjeq1784htp9v954je22hp1vef